Swiss pharma giant says it's 'too soon' to know whether malaria drug could be coronavirus vaccine

The CEO of Novartis has said it is "too soon" to know whether two anti-malaria drugs could be the definitive vaccine for the coronavirus.

from Health and Science https://ift.tt/39pZLG6
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH